For STEM students considering career paths, the PA, NJ, & DE region is recognized as one of the leading biotechnology & ...

The initiative aims to identify important assets critical to improving human health and to cultivate the next generation of pharmaceutical industry business leaders. Future Labs is part of Apimeds’ ...

David Reese believes that AI’s greatest impact will come from improving the thousands of human-led decisions. If Reese, the ...

MATAWAN, N.J.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (APUS) (“Apimeds”) today announced the expansion of its ai² Future Labs program by engaging graduate students from the University of ...

In the fast-paced world of biotechnology, success hinges on more than groundbreaking science—it requires the right connections, strategic partnerships, and access to capital. Biotech Showcase delivers ...

Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelini Ventures Global Intelligence Hub, leveraging its ...

Over the past few years, we have been deeply engaged in – and have closely observed – the rapid growth of Chinese biotech companies. Despite a challenging market environment, these companies have ...

Alchemab Therapeutics has appointed Ulrich Wendt, PhD MBA, as Chief Business Officer (CBO) to expand partnerships with biopharma for the development of novel antibody therapeutics. As a proven ...

Damian Garde joins Allison, Adam, and Elaine to discuss his article about Boris Nikolic, a well-connected biotech investor ...

Aurion Biotech today named Dr. Marjan Farid, Director of Cornea, Cataract, and Refractive Surgery and a Clinical Professor at ...

MATAWAN, N.J.--(BUSINESS WIRE)--Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of ...

Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced ...